Page last updated: 2024-10-22

amitriptyline and Diabetes Mellitus, Gestational

amitriptyline has been researched along with Diabetes Mellitus, Gestational in 2 studies

Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Wang, XY1
Ying, XH1
Jiang, HY1
Dandjinou, M1
Sheehy, O1
BĂ©rard, A1

Reviews

1 review available for amitriptyline and Diabetes Mellitus, Gestational

ArticleYear
Antidepressant use during pregnancy and the risk for gestational diabetes: a systematic review and meta-analysis.
    The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2023, Volume: 36, Issue:1

    Topics: Amitriptyline; Antidepressive Agents; Diabetes, Gestational; Female; Humans; Pregnancy; Selective Se

2023

Other Studies

1 other study available for amitriptyline and Diabetes Mellitus, Gestational

ArticleYear
Antidepressant use during pregnancy and the risk of gestational diabetes mellitus: a nested case-control study.
    BMJ open, 2019, 10-01, Volume: 9, Issue:9

    Topics: Adolescent; Adult; Amitriptyline; Antidepressive Agents; Case-Control Studies; Cohort Studies; Depre

2019